Niclosamide or Pyrvinium and BAY-876 as a Combination for Triple Negative Breast Cancer Treatment

Project: Research project

Project Details

Description

Niclosamide or Pyrvinium and BAY-876 as a Combination for Triple Negative Breast Cancer Treatment
StatusActive
Effective start/end date1/1/2212/31/22

Funding

  • Whiteside Inst. for Clinical Research

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.